Aligos Therapeutics
Price & Volume
Stats
See more52W Range | $6.76-$46.80 |
Market Cap | $56.1M |
Shares Short | 795,342 |
Financials
See moreRevenue (12 Mos) | $3.9M |
Revenue Growth (YoY) | -76.5% |
Gross Profit (12 Mos) | -$66.3M |
Diluted EPS | -$20.94 |
News
See moreYahoo Finance • 6 days ago
Aligos Therapeutics Presents Positive Data at APASL 2025
Yahoo Finance • 18 days ago
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 29 days ago
Aligos Therapeutics to Announce 4th Quarter 2024 Financial Results on March 10, 2025
Yahoo Finance • last year
13 Stocks Insiders are Buying Now
About
CEO | Dr. Lawrence M. Blatt MBA, Ph.D. |
CFO | Ms. Lesley Ann Calhoun CPA |
Address | One Corporate Drive, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 70 |
